PF
ORGS

Phoenix Financial’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Phoenix Financial’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-74,204
Closed -$3.33M – 489
2020
Q4 		$3.33M Sell
74,204
-285
-0.4% -$13.7K 0.09% 165
2020
Q3 		$3.54M Sell
74,489
-1,994
-3% -$108K 0.15% 115
2020
Q2 		$4.42M Sell
76,483
-42,590
-36% -$2.58M 0.19% 115
2020
Q1 		$4.42M Buy
119,073
+112,673
+1,761% +$4.92M 0.22% 110
2019
Q4 		$296K Hold
6,400
– – 0.01% 182
2019
Q3 		$273K Buy
+6,400
New +$286K 0.01% 175

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RC
Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return

Phoenix Financial's ORGS Position: Q1 2021 in Review

Phoenix Financial sold out of Orgenesis Inc. Common Stock (ORGS) in Q1 2021, closing a stake of 74,204 shares — an estimated $3.33M sold.

Phoenix Financial first reported a position in ORGS in Q3 2019 and held it in 6 quarters. The position peaked at $4.42M in Q1 2020. 39 funds tracked by Wall St. Rank hold ORGS as of Q1 2021.

  • Phoenix Financial reported no remaining Orgenesis Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Phoenix Financial sold 74,204 Orgenesis Inc. Common Stock shares in Q1 2021, an estimated $3.33M.
  • Phoenix Financial first reported a position in Orgenesis Inc. Common Stock in Q3 2019 and held it in 6 quarters.
  • Phoenix Financial's Orgenesis Inc. Common Stock position peaked at $4.42M in Q1 2020.
  • 39 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q1 2021.

Based on Phoenix Financial's 13F filing for Q1 2021, filed 10 May 2021.